Back to search results

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

Abroad (travel likely)RecruitingPHASE1

Conditions

Melanoma (Skin) · Triple-Negative Breast Cancer · Non-Small Cell Lung Cancer · Synovial Sarcoma · Myxoid Liposarcoma · Colorectal Cancer · Osteosarcoma · Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Krankenhaus Nordwest, Frankfurt, Germany

  • National Center for Tumor Diseases, Heidelberg, Germany

  • Universitätsklinikum Tübingen, Tübingen, Germany

  • Istituto di Candiolo Fondazione del Piemonte per l'oncologia IRCCS, Candiolo, Italy

    Contact: Study coordinator (Vanesa Gregorc) · vanesa.gregorc@ircc.it

  • IRCCS Istituto Clinico Humanitas, Milan, Italy

    Contact: Study coordinator (Matteo Simonelli) · matteo.simonelli@hunimed.eu

  • IRCCS Ospedale San Raffaele, Milan, Italy

    Contact: Study coordinator (Gianluca Del Conte) · delconte.gianluca@hsr.it

  • Università di Napoli Federico II, Naples, Italy

    Contact: Study coordinator (Roberto Bianco) · robianco@unina.it
View source on ClinicalTrials.gov(opens in a new tab)